Cancer Incidence Trends From 1999 to 2015 And Contributions Of Various Cancer Types To The Overall Burden: Projections To 2030 And Extrapolation Of Economic Burden In Saudi Arabia
- PMID: 32009819
- PMCID: PMC6861167
- DOI: 10.2147/CMAR.S222667
Cancer Incidence Trends From 1999 to 2015 And Contributions Of Various Cancer Types To The Overall Burden: Projections To 2030 And Extrapolation Of Economic Burden In Saudi Arabia
Abstract
Background: Cancer incidence in Saudi Arabia has increased for the last two decades, ratcheting up to global levels. The study aimed to analyze cancer trends and the contributions of various cancer types, forecast incidence, and estimate the economic burden in 2030.
Methods: A national-level cohort study utilizing the Data of Cancer Registry of patients who were diagnosed in 1999-2015. New cases in 2016-2030 were forecast and predicted based on 1999-2015 data. We used growth assumption and regression analysis to predict the trends of cancer cases. We assessed the contributions of cancer types to incidence trends. We carried forecasting of new cases and extrapolation of the potential economic burden. We conducted a sensitivity analysis of the cost of cancer with respect to changes in economic and epidemiologic factors.
Results: The findings suggest that the number of known cancer cases increased by 136% from 1999 to 2015 and is projected to rise by 63% in 2030. The forecast indicates female cases will account for higher number of cases and greater proportion increase. The future cost of all cancer types would be estimated at $7.91 billion in 2015 value, of which $3.76 billion will be attributable to care management and $4.15 billion in lost productivity. With the assumption of growth of the aged-standardized incidence rate, the costs of care management and lost productivity are projected to be $5.85 and $6.47 billion, respectively in 2030, an increase of 56% in each component. The future undiscounted total estimated economic burden for the period 2015-2030 would be $159.44 billion, of which 47.5% will be attributable to care management. Estimates were robust to uncertainty, but the 5-year prevalence of cancer survivorship would account for the greatest variability.
Conclusion: Our model showed an upsurge of cancer burden in terms of incidence and the potential economic burden, which may inform cancer control measures.
Keywords: Saudi Arabia; cancer economic burden; cancer trends; the 2030 cancer burden projection.
© 2019 Jazieh et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures



Similar articles
-
The Burden, Future Trends, And Economic Impact Of Lung Cancer In Saudi Arabia.Clinicoecon Outcomes Res. 2019 Nov 19;11:703-712. doi: 10.2147/CEOR.S224444. eCollection 2019. Clinicoecon Outcomes Res. 2019. PMID: 31819562 Free PMC article.
-
A finite and stable exponential growth-adjusted indirect cost of cancer associated with discounted years of life lost in Saudi Arabia.Heliyon. 2018 May 31;4(5):e00637. doi: 10.1016/j.heliyon.2018.e00637. eCollection 2018 May. Heliyon. 2018. PMID: 29872769 Free PMC article.
-
Reassessment of osteoporosis-related femoral fractures and economic burden in Saudi Arabia.Arch Osteoporos. 2015;10:37. doi: 10.1007/s11657-015-0240-5. Epub 2015 Oct 22. Arch Osteoporos. 2015. PMID: 26494131
-
Cancer Control Priorities and Challenges in Saudi Arabia: A Preliminary projection of Cancer Burden.Gulf J Oncolog. 2019 Jan;1(29):22-30. Gulf J Oncolog. 2019. PMID: 30956193 Review.
-
The burden of osteoporosis in Saudi Arabia: a scorecard and economic model.J Med Econ. 2020 Jul;23(7):767-775. doi: 10.1080/13696998.2020.1737536. Epub 2020 Mar 17. J Med Econ. 2020. PMID: 32122190
Cited by
-
Improving Utilization of the Chemotherapy Unit through Implementing the Medication Early Release Project.Glob J Qual Saf Healthc. 2023 Aug 24;6(3):81-88. doi: 10.36401/JQSH-23-8. eCollection 2023 Aug. Glob J Qual Saf Healthc. 2023. PMID: 38405331 Free PMC article.
-
Levels and predictors of fear and health anxiety during the current outbreak of COVID-19 in immunocompromised and chronic disease patients in Saudi Arabia: A cross-sectional correlational study.PLoS One. 2021 Apr 26;16(4):e0250554. doi: 10.1371/journal.pone.0250554. eCollection 2021. PLoS One. 2021. PMID: 33901260 Free PMC article.
-
Repurposing of Indomethacin and Naproxen as anticancer agents: progress from 2017 to present.RSC Adv. 2024 Dec 23;14(54):40031-40057. doi: 10.1039/d4ra07581a. eCollection 2024 Dec 17. RSC Adv. 2024. PMID: 39717807 Free PMC article. Review.
-
A detailed insight of the tumor targeting using nanocarrier drug delivery system.Drug Deliv. 2023 Dec;30(1):2183815. doi: 10.1080/10717544.2023.2183815. Drug Deliv. 2023. PMID: 36866455 Free PMC article. Review.
-
Clinical and Therapeutic Characteristics of Cancer Patients in the Southern Region of Saudi Arabia: A Cross-Sectional Study.Int J Environ Res Public Health. 2021 Jun 21;18(12):6654. doi: 10.3390/ijerph18126654. Int J Environ Res Public Health. 2021. PMID: 34205637 Free PMC article.
References
-
- Institute for Health Metrics and Evaluation (IHME). The Global Burden of Disease Study 2017. Institute for Health Metrics and Evaluation, Seattle, WA; 2018.
-
- World Health Organization. Report on the regional meeting on cancer control and research priorities Doha, Qatar 20–22 October 2013. 2013.
-
- Gulf Centre for Cancer Registration. Cancer Incidence Report: Gulf Cooperation Council Countries. Riyadh, Saudi Arabia:GCCR; 2014.
-
- Ministry of Health. Cancer Incidence Report Saudi Arabia 2014. Ministry of Health, Riyadh; 2014.
LinkOut - more resources
Full Text Sources